Adicet Bio, Inc. Business Combination, Contingent Consideration, Liability
Adicet Bio, Inc. (ACET) had Business Combination, Contingent Consideration, Liability of $600.00 thousand as of 2021-03-31, per its 10-Q filed 2021-05-17.
Discontinued › Balance Sheet › Liabilities
us-gaap:BusinessCombinationContingentConsiderationLiability · last filed 2022-03-15
- 2021-03-31: Business Combination, Contingent Consideration, Liability $600.00K.
- 2020-12-31: Business Combination, Contingent Consideration, Liability $980.00K.
- 2020-09-30: Business Combination, Contingent Consideration, Liability $2.88M.
| Period end | Business Combination, Contingent Consideration, Liability |
|---|---|
| 2021-03-31 | $600.00K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $980.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $2.88M 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |